Key result
Flash glucose monitoring significantly increased the median proportion of time in target glycemic range (70-180 mg/dL) to 64.5% compared to 43.2% with standard capillary monitoring.
Why the study?
To evaluate the effectiveness of the Flash glucose monitoring device compared to the Accu Chek glucometer in patients with type 1 diabetes mellitus.
Does Flash Glucose Monitoring improve glycemic control compared to capillary blood glucose monitoring in adults with Type 1 Diabetes Mellitus?
Cohort (n=30)
Open-label
No
Does Flash Glucose Monitoring improve glycemic control compared to capillary blood glucose monitoring in adults with Type 1 Diabetes Mellitus?
Flash glucose monitoring significantly increases time in range and reduces hyperglycemia compared to traditional capillary blood glucose monitoring in adults with Type 1 Diabetes Mellitus.
Answers are grounded in this paper and cite their sources.
May support flash glucose monitoring; leaves open need for randomized trials before practice change.
Objective: to evaluate the effectiveness of the Flash glucose device compared to the Accu Chek glucometer in Type 1 Diabetes Mellitus (T1DM). Methods: thirty patients with T1DM and age over 18 years, treated at a tertiary hospital, were recruited. To verify the effectiveness of the FGM device, the average proportion of blood glucose levels in the target (range 70 to 180 mg/dL), level 2 hyperglycemia (> 250mg/dL) and level 2 hypoglycemia (<54mg/dL) were evaluated separately. Subsequently, the proportion of blood glucose in these ranges was compared between the two devices. Results: the use of the FGM, when compared to the Accu-Chek system, made it possible to increase the proportion of blood glucose levels on Time in Range (70 to 180 mg/dl) by 51% (Libre 65% & Accu-Chek 43%) and the reduction in level 2 hyperglycemia of 90.48% (Libre 2% versus Accu-Check 21%). However, the FGM system was not able to reduce the level 2 hypoglycemia occurrence. Conclusions: the Flash monitoring technology seem an effective tool for glycemic control in patients with T1DM.
No takes yet. Share an insight, caveat, or question.
Young et al. (2025) conducted a cohort in Type 1 Diabetes Mellitus (n=30). Flash Glucose Monitoring (FreeStyle Libre) vs. Capillary Blood Glucose Monitoring (Accu-Chek) was evaluated on Proportion of blood glucose levels in Time in Range (70 to 180 mg/dL) (p=0.0001). Flash glucose monitoring significantly increased the median proportion of time in target glycemic range (70-180 mg/dL) to 64.5% compared to 43.2% with standard capillary monitoring.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: